Percutaneous devices for stroke prevention

被引：13

作者：

Bayard, Yves L. ^{[1
]}

Ostermayer, Stefan H. ^{[1
]}

Hein, Ralph ^{[1
]}

Skowasch, Marijke ^{[1
]}

Bqscheck, Franziska ^{[1
]}

Baranowski, Andreas ^{[1
]}

Heinisch, Corinna ^{[1
]}

Sievert, Horst ^{[1
]}

机构：

[1] CardioVasc Ctr Frankfurt, Seckbacher Landstr 65, D-60389 Frankfurt, Germany

来源：

CARDIOVASCULAR REVASCULARIZATION MEDICINE | 2007年 / 8卷 / 03期

关键词：

Cryptogenic stroke; Stroke prevention; Patent foramen ovale; Atrial fibrillation; Left atrial appendage;

D O I：

10.1016/j.carrev.2007.01.005

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The most important approaches to prevent cerebral ischemia by catheter technique are patent foramen ovale (PFO) closure in patients with a history of cryptogenic stroke and left atrial appendage (LAA) occlusion in atrial fibrillation (AF) patients. Over the past years, several new devices have been developed for these procedures. Results of randomized trials comparing device therapy, antiplatelet, or anticoagulation therapy are still not available. However, several nonrandomized studies have shown promising results. This article gives a review on the current results and techniques of the most commonly used devices as well as on new developments and approaches to catheter- based stroke prevention. (C) 2007 Elsevier Inc. All rights reserved.

引用

页码：216 / 225

页数：10

共 66 条

[1] Transcatheter patent foramen ovale closure for secondary prevention of paradoxical embolic events: Acute results from the FORECAST registry [J].

Alameddine, F ;

Block, PC .

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2004, 62 (04) :512-516

[2]

Bayard YL, 2006, 9 INT WORKSH CATH IN

[3] Transcatheter closure as standard treatment for most interatrial defects:: experience in 200 patients treated with the Amplatzer™ Septal Occluder [J].

Berger, F ;

Ewert, P ;

Björnstad, PG ;

Dähnert, I ;

Krings, G ;

Brilla-Austgenat, I ;

Vogel, M ;

Lange, PE .

CARDIOLOGY IN THE YOUNG, 1999, 9 (05) :468-473

[4]

Billinger K, 2001, EUROINTERVENTION, V6, P465

[5] Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation [J].

Blackshear, JL ;

Odell, JA .

ANNALS OF THORACIC SURGERY, 1996, 61 (02) :755-759

[6] Stroke recurrence in patients with patent foramen ovale: The Lausanne Study [J].

Bogousslavsky, J ;

Garazi, S ;

Jeanrenaud, X ;

Aebischer, N ;

VanMelle, G .

NEUROLOGY, 1996, 46 (05) :1301-1305

[7] ACC/AHA guidelines for the management of patients with valvular heart disease - A report of the American College of Cardiology American Heart Association Task Force on practice guidelines (Committee on Management of Patients with Valvular Heart Disease) [J].

Bonow, RO ;

Carabello, B ;

De Leon, AC ;

Edmunds, LH ;

Fedderly, BJ ;

Freed, MD ;

Gaasch, WH ;

Mckay, CR ;

Nishimura, RA ;

O'Gara, PT ;

O'Rourke, RA ;

Rahimtoola, SH .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 32 (05) :1486-1582

[8] Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism - Periprocedural safety and mid-term follow-up results of three different device occluder systems [J].

Braun, M ;

Gliech, V ;

Boscheri, A ;

Schoen, S ;

Gahn, G ;

Reichmann, H ;

Haass, M ;

Schraeder, R ;

Strasser, RH .

EUROPEAN HEART JOURNAL, 2004, 25 (05) :424-430

[9] TRANSCATHETER CLOSURE OF PATENT FORAMEN OVALE AFTER PRESUMED PARADOXICAL EMBOLISM [J].

BRIDGES, ND ;

HELLENBRAND, W ;

LATSON, L ;

FILIANO, J ;

NEWBURGER, JW ;

LOCK, JE .

CIRCULATION, 1992, 86 (06) :1902-1908

[10]

Buscheck Franziska, 2006, J Interv Cardiol, V19, P328, DOI 10.1111/j.1540-8183.2006.00154.x

← 1 2 3 4 5 6 7 →